Quick Takeaways
- This page summarizes Solomon Moshkevich's Form 4 filing for Natera, Inc. (NTRA).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 11 Mar 2026, 18:05.
Solomon Moshkevich - 09 Mar 2026 Form 4 Insider Report for Natera, Inc. (NTRA)
- Signature
- /s/ Tami Chen, Attorney-in-Fact
- Issuer symbol
- NTRA
- Transactions as of
- 09 Mar 2026
- Net transactions value
- -$186,781
- Form type
- 4
- Filing time
- 11 Mar 2026, 18:05:05 UTC
- Previous filing
- 03 Mar 2026
- Next filing
- 03 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Solomon Moshkevich filed Form 4 for Natera, Inc. (NTRA) on 11 Mar 2026."
What Changed
- Previous filing in this sequence was filed on 03 Mar 2026.
- Current net transaction value: -$186,781.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN | /s/ Tami Chen, Attorney-in-Fact | 11 Mar 2026 | 0002010019 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTRA | Common Stock | Award | +1,774 | +1.2% | 151,797 | 09 Mar 2026 | Direct | F1, F2 | ||
| transaction | NTRA | Common Stock | Sale | $186,781 | -915 | -0.6% | $204.13 | 150,882 | 10 Mar 2026 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. |
| F2 | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| F3 | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 9, 2026. |